Literature DB >> 30154153

Transcription Factor PROX1 Suppresses Notch Pathway Activation via the Nucleosome Remodeling and Deacetylase Complex in Colorectal Cancer Stem-like Cells.

Jenny Högström1, Sarika Heino1, Pauliina Kallio1, Marianne Lähde1, Veli-Matti Leppänen1, Diego Balboa2, Zoltán Wiener1, Kari Alitalo3.   

Abstract

The homeobox transcription factor PROX1 is induced by high Wnt/β-catenin activity in intestinal adenomas and colorectal cancer, where it promotes tumor progression. Here we report that in LGR5+ colorectal cancer cells, PROX1 suppresses the Notch pathway, which is essential for cell fate in intestinal stem cells. Pharmacologic inhibition of Notch in ex vivo 3D organoid cultures from transgenic mouse intestinal adenoma models increased Prox1 expression and the number of PROX1-positive cells. Notch inhibition led to increased proliferation of the PROX1-positive colorectal cancer cells, but did not affect their ability to give rise to PROX1-negative secretory cells. Conversely, PROX1 deletion increased Notch target gene expression and NOTCH1 promoter activity, indicating reciprocal regulation between PROX1 and the Notch pathway in colorectal cancer. PROX1 interacted with the nucleosome remodeling and deacetylase (NuRD) complex to suppress the Notch pathway. Thus, our data suggests that PROX1 and Notch suppress each other and that PROX1-mediated suppression of Notch mediates its stem cell function in colorectal cancer.Significance: These findings address the role of the PROX1 homeobox factor as a downstream effector of Wnt/β-catenin singling in colorectal cancer stem cells and show that PROX1 inhibits the Notch pathway and helps to enforce the stem cell phenotype and inhibit differentiation. Cancer Res; 78(20); 5820-32. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30154153     DOI: 10.1158/0008-5472.CAN-18-0451

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice.

Authors:  Simone Ragusa; Borja Prat-Luri; Alejandra González-Loyola; Sina Nassiri; Mario Leonardo Squadrito; Alan Guichard; Sabrina Cavin; Nikolce Gjorevski; David Barras; Giancarlo Marra; Matthias P Lutolf; Jean Perentes; Emily Corse; Roberta Bianchi; Laureline Wetterwald; Jaeryung Kim; Guillermo Oliver; Mauro Delorenzi; Michele De Palma; Tatiana V Petrova
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 2.  The Methyl-CpG-Binding Domain 2 and 3 Proteins and Formation of the Nucleosome Remodeling and Deacetylase Complex.

Authors:  Gage Leighton; David C Williams
Journal:  J Mol Biol       Date:  2019-10-15       Impact factor: 5.469

3.  miR-934 as a Prognostic Marker Facilitates Cell Proliferation and Migration of Pancreatic Tumor by Targeting PROX1.

Authors:  Yangbing Jin; Yuanchi Weng; Yue Wang; Jiewei Lin; Xiaxing Deng; Baiyong Shen; Qian Zhan; Xiongxiong Lu
Journal:  Onco Targets Ther       Date:  2020-04-22       Impact factor: 4.147

Review 4.  Ras Pathways on Prox1 and Lymphangiogenesis: Insights for Therapeutics.

Authors:  Khoa Bui; Young-Kwon Hong
Journal:  Front Cardiovasc Med       Date:  2020-11-12

5.  WNT signaling and cancer stemness.

Authors:  Masuko Katoh; Masaru Katoh
Journal:  Essays Biochem       Date:  2022-09-16       Impact factor: 7.258

Review 6.  Precision medicine for human cancers with Notch signaling dysregulation (Review).

Authors:  Masuko Katoh; Masaru Katoh
Journal:  Int J Mol Med       Date:  2019-12-04       Impact factor: 4.101

Review 7.  Chromatin Dynamics in Intestinal Epithelial Homeostasis: A Paradigm of Cell Fate Determination versus Cell Plasticity.

Authors:  Jérémie Rispal; Fabrice Escaffit; Didier Trouche
Journal:  Stem Cell Rev Rep       Date:  2020-10-13       Impact factor: 5.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.